Weiss Response to Sengupta et al. (DOI: 10.1089/scd.2020.0095)

Daniel J Weiss¹, Sai Kiang Lim², Eva Rohde^{3

4

5}, Kenneth W Witwer^{6

7}, Bernd Giebel⁸

Affiliations

¹ Department of Medicine, University of Vermont, Burlington, Vermont, USA.
² Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, Singapore.
³ GMP Unit, Spinal Cord Injury & Tissue Regeneration Centre Salzburg (SCI-TReCS) Paracelsus Medical University (PMU), Salzburg, Austria.
⁴ Department of Transfusion Medicine, University Hospital, Salzburger Landeskliniken GesmbH (SALK), Paracelsus Medical University (PMU), Salzburg, Austria.
⁵ Research and Transfer Center for Extracellular Vesicle Theralytic Technologies (EV-TT), Salzburg, Austria.
⁶ Department of Molecular and Comparative Pathobiology and The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
⁷ Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
⁸ Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Comment

Daniel J Weiss et al. Stem Cells Dev. 2020 Dec.

. 2020 Dec;29(24):1533-1534.

doi: 10.1089/scd.2020.0114.

Daniel J Weiss¹, Sai Kiang Lim², Eva Rohde^{3

4

5}, Kenneth W Witwer^{6

7}, Bernd Giebel⁸

¹ Department of Medicine, University of Vermont, Burlington, Vermont, USA.
² Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, Singapore.
³ GMP Unit, Spinal Cord Injury & Tissue Regeneration Centre Salzburg (SCI-TReCS) Paracelsus Medical University (PMU), Salzburg, Austria.
⁴ Department of Transfusion Medicine, University Hospital, Salzburger Landeskliniken GesmbH (SALK), Paracelsus Medical University (PMU), Salzburg, Austria.
⁵ Research and Transfer Center for Extracellular Vesicle Theralytic Technologies (EV-TT), Salzburg, Austria.
⁶ Department of Molecular and Comparative Pathobiology and The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
⁷ Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
⁸ Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

No abstract available

Comment on

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Sengupta V, et al. Stem Cells Dev. 2020 Jun 15;29(12):747-754. doi: 10.1089/scd.2020.0080. Epub 2020 May 12. Stem Cells Dev. 2020. PMID: 32380908 Free PMC article. Clinical Trial.